RSS

counterfeit medicines

Stanley Chia, senior vice president at e-invoicing supplier, Tungsten Network, details the importance of secure supply chains in the age of the counterfeit drug. Read more

Opinion 2 Comments

In advance of new European measures to help reduce counterfeit medicines, Wayne Miller, healthcare director EMEA at Zebra Technologies, asks if the pharmaceutical supply chain is ready for true medicine traceability. Read more

Opinion

A haul of fake medicines worth over £2 million was seized by the Medicines and Healthcare products Regulatory Agency (MHRA) in a crackdown on counterfeit and unlicensed drugs. Read more

News

After learning that pharma giant, Merck, has filed for a US patent for a blockchain-based system, GlobalData has been led to believe that the first applications of blockchain will initially be seen in the healthcare supply chain Read more

Analysis

Swiss pharmaceutical group, Helsinn, has revealed it will be investing €6 million at its drug product supply centre (Helsinn Birex Pharmaceuticals — HBP) in Dublin, Ireland, to safeguard its supply chain and compliance with regulatory requirements Read more

News

As the EU Falsified Medicines Directive (FMD) legislation deadline draws closer, Solidsoft Reply has revealed that the first seven countries to go live with the National Medicines Verification System have chosen its National Blueprint systems. Read more

Technology

Here, Mario Scigliano, serialisation & automation manager, and Christian Ahlmark, associate director, sales & key account management, CordenPharma, discuss how a CDMO can help give companies a fighting chance to be globally serialisation compliant. Read more

, Opinion

Bio/pharmaceutical analytical and bioanalytical contract solutions provider, SGS, has entered into a partnership with Nature’s Fingerprint to combat pharmaceutical counterfeiting Read more

News

Arvato Systems has been tasked with the implementation and operation of the Medication Verification IT platform for the Austrian Medicines Verification Organisation (AMVO). Read more

News

After recent events, it seems that more than ever protective measures are made to ensure pharma is a safe space for companies and patients. Read more

Opinion

Erik Haeffler, vice president of manufacturing services, Recipharm, examines the challenges and opportunities for a CDMO in the landscape of serialisation that contract partners must overcome. Read more

Opinion

Jean-Marc Bobée, former director, industrial anti-counterfeiting strategy at Sanofi, outlines global and local traceability concepts and their individual ‘security to cost’ ratios, highlighting the need for a standardised global serialisation Read more

Opinion

In this article, Mark Usher of Solidsoft Reply, explains the challenges of deploying multiple connected national systems for the large-scale European pharmaceutical industry. Read more

Opinion

Denny Bros’ senior marketing executive, Stephie Castling, explains how to stay ahead of the fraudsters. Read more

News

As manufacturers await the implementation of the falsified medicines directive, Nadine Lampka product manager, pharma-security at Schreiner MediPharm examines the state of play. Read more

News

Thanks to a smartphone app both manufacturers and consumers can verify the authenticity of drugs anytime, anywhere. Read more

News

Healthcare professionals and policymakers at the World Health Professions Alliance (WHPA) are challenging counterfeit medicines by asking the public - Would you be able to tell a real medicine from a fake one? Read more

News

Farzad Henareh, Stericycle ExpertSolutions, discusses ‘fake Europe’ and the impact of counterfeit pharmaceutical products Read more

Opinion

One of the main themes at Pharmapack Europe 2016 was serialisation and the industry’s efforts to overcome counterfeiting in pharmaceuticals Read more

News

Ian Lemon, Essentra, looks at the issues the pharmaceutiucal sector faces with counterfeiting and where the future of packaging is heading Read more

Opinion